A resting pulse above roughly 80 beats per minute in someone with chronic kidney disease (CKD) is not just a side note on a vital-signs chart; it is an independent signal of higher cardiovascular risk and shorter survival. Studies of CKD patients who do not yet need dialysis show that those with resting heart rates at or above 90 beats per minute face more than double the risk of death compared to patients whose hearts beat below 70 per minute. The reasons behind that faster pulse reach into nearly every system the failing kidneys influence, from overactive stress nerves to low red blood cell counts to stiffening arteries.
How Common Is an Elevated Pulse in CKD
Heart rate tends to creep upward as kidney function declines, even in people who feel fine at rest. In a large Korean population survey, adults whose resting heart rate sat at 90 or above were roughly twice as likely to have CKD as those whose pulse stayed under 60, with similar magnitudes in both men and women.1PubMed Central. Resting rate is associated with the prevalence of chronic kidney disease in Korean adult: the Korean National Health and Nutrition Survey That relationship works in both directions: kidney disease raises heart rate, and a higher heart rate may itself accelerate kidney damage. Across CKD cohorts, the median resting pulse tends to land in the mid-70s, but a meaningful fraction of patients consistently runs in the 80s or above. Women and people with diabetes are more frequently represented in the higher-heart-rate brackets, as is atrial fibrillation, which appeared in close to 9 percent of subjects in one CKD study.2PubMed Central. Elevated resting heart rate is associated with mortality in patients with chronic kidney disease
Why CKD Pushes the Pulse Higher
There is no single switch that flips to speed up the heart in kidney disease. Instead, several overlapping mechanisms pile on top of each other, and a given patient may be affected by several at once.
Sympathetic Nervous System Overdrive
The biggest driver is an overactive “fight-or-flight” system. The sympathetic nervous system, which controls involuntary responses like heart rate and blood vessel tone, runs on high in most CKD patients. Over 80 percent of people with CKD have hypertension, and that persistent high blood pressure is tightly linked to elevated sympathetic nerve activity.3PubMed Central. Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms Elevated sympathetic tone does not merely accompany CKD; it worsens its progression and raises cardiovascular risk independent of blood pressure. In practical terms, the body acts as though it is under constant low-grade stress, keeping the heart beating faster than it otherwise would.
Anemia and Low Oxygen Delivery
Healthy kidneys produce erythropoietin, the hormone that stimulates red blood cell production. As kidneys fail, erythropoietin output drops, and anemia develops. When fewer red blood cells are available to carry oxygen, the heart compensates by pumping faster and harder. The increase in heart rate during anemia is driven both by oxygen-sensing chemoreceptors and by the sympathetic activation already described above.4PubMed. Pathophysiology of anaemia: focus on the heart and blood vessels In severe CKD, this compensatory tachycardia can become chronic, contributing to cardiac enlargement over time.
Arterial Stiffness
CKD accelerates the stiffening and calcification of blood vessel walls. The combination of oxidative stress, chronic inflammation, and calcium deposits in the arterial wall makes arteries less elastic, which forces the heart to work harder to push blood through the circulation.5PubMed Central. Chronic Kidney Disease and Arterial Stiffness: A Two-Way Path Stiffer arteries also impair the baroreflexes, which are the body’s built-in brake system for heart rate. Normally when blood pressure rises, baroreceptors signal the heart to slow down. In CKD patients with stiff vessels, those signals become weaker and less reliable, removing a natural check on pulse rate.
Uremic Toxins and Autonomic Dysfunction
As kidneys lose their filtering capacity, waste products that would normally be excreted build up in the blood. These uremic toxins appear to directly disrupt the autonomic nervous system’s regulation of the heart. Evidence for this comes from dialysis research: intensive hemodialysis, which clears toxins more aggressively, has been shown to improve both sympathetic overactivity and the sensitivity of the cardiac baroreflex.6PubMed. Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease? That improvement after toxin removal strongly suggests that the toxins themselves are part of the problem, not just a bystander.
Electrolyte Imbalances
The kidneys are the body’s primary electrolyte regulators. When they fail, levels of potassium, magnesium, calcium, and sodium can all shift in ways that directly affect the electrical activity of the heart. Abnormal potassium levels are particularly dangerous: too high or too low can trigger fast or irregular heart rhythms. Metabolic acidosis, which is common in advanced CKD, further compounds the problem by shifting potassium out of cells and altering the heart’s electrical stability.7PubMed Central. Acid-Base and Electrolyte Disorders in Patients with and without Chronic Kidney Disease: An Update
How a Faster Pulse Affects Survival
The link between elevated resting heart rate and death in CKD is dose-dependent: the faster the resting pulse, the worse the outlook. In a study of patients with non-dialysis CKD, after adjusting for age, sex, diabetes, blood pressure medications, and other factors, those with a resting heart rate between 80 and 89 had about 1.7 times the risk of dying from any cause compared with patients whose heart rate was below 70. For those at 90 or above, the risk roughly tripled.2PubMed Central. Elevated resting heart rate is associated with mortality in patients with chronic kidney disease An earlier study of CKD patients reached strikingly similar conclusions: compared to those in the 60-to-74 range, patients with resting heart rates of 75 to 89 had about three times the mortality risk, and those at 90-plus had nearly four times the risk.8Nephrology Dialysis Transplantation. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease
Cardiovascular events specifically, not just death from any cause, also track with pulse rate. The 80-to-89 group showed roughly 1.7 times the risk of cardiovascular events in the more recent study.2PubMed Central. Elevated resting heart rate is associated with mortality in patients with chronic kidney disease Interestingly, the relationship between heart rate and all-cause mortality follows a U-shaped curve: very low resting heart rates also carry some risk, likely because they can reflect underlying conduction abnormalities or severe cardiac damage. The sweet spot appears to sit somewhere in the 60s to low 70s.
The earlier study also flagged a connection between faster heart rate and insulin resistance in CKD patients, suggesting that the metabolic consequences of sympathetic overdrive extend beyond the heart itself.8Nephrology Dialysis Transplantation. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease This reinforces the idea that an elevated pulse is not just a marker of trouble but a participant in a larger web of metabolic harm.
How Dialysis Itself Changes Heart Rate
For patients who have progressed to hemodialysis, the treatment session becomes its own cardiovascular stressor. During a typical dialysis run, large volumes of fluid are removed over just a few hours, and the body’s autonomic system has to scramble to keep blood pressure from crashing. Studies have found that heart rate rises during and immediately after hemodialysis. In one study, average heart rate climbed from about 75 beats per minute before the session to about 80 afterward, with a simultaneous shift toward greater sympathetic dominance.9PubMed Central. Dynamics of Cardiac Autonomic Responses During Hemodialysis Measured by Heart Rate Variability and Skin Sympathetic Nerve Activity: The Impact of Interdialytic Weight Gain The amount of fluid gained between sessions matters: the more weight a patient has accumulated, the larger the fluid removal and the more dramatic the autonomic swings.
Heart rate variability, which measures how much the interval between heartbeats fluctuates, is an established proxy for autonomic health. In CKD patients on dialysis, variability indices generally return to baseline once the session ends and the body stabilizes. However, the autonomic response to physical stress remains exaggerated for hours afterward, returning to normal only on the next non-dialysis day.10PubMed. Hemodialysis Effects on Autonomic Function: Results of Linear and Nonlinear Analysis of Heart Rate Variability at Rest and in Response to Physical and Mental Stress Tests This means that CKD patients on hemodialysis experience a recurring cycle of autonomic stress and partial recovery, three or more times per week. That chronic autonomic turbulence is one reason dialysis patients face such high rates of arrhythmia and sudden cardiac death.
Heart Rate Variability as a Monitoring Tool
Beyond simply counting how fast the heart beats, researchers are paying increasing attention to heart rate variability in CKD. A steady, metronome-like heartbeat might sound desirable, but it actually reflects poor autonomic flexibility. Healthy hearts speed up and slow down in subtle, beat-to-beat patterns in response to breathing, posture changes, and mental activity. When that variability shrinks, it indicates that the autonomic nervous system has lost some of its responsiveness, often because of the sympathetic overdrive, baroreflex impairment, and uremic toxin effects already described.
In a prospective study of over 300 CKD patients (stages 3 through 5) who wore 24-hour heart monitors, reduced heart rate variability was identified as both a marker of cardiovascular disease risk and a potential prognostic tool.11PubMed Central. Predictors of heart rate variability and its prognostic significance in chronic kidney disease This kind of monitoring could eventually help clinicians spot patients whose autonomic dysfunction is worsening before a catastrophic event occurs, although at the moment it remains more of a research tool than a standard clinical practice.
Can Beta-Blockers Help
Beta-blockers, which directly slow the heart by blocking adrenaline’s effects, are a logical candidate for treating the elevated pulse in CKD. But kidney disease complicates their use because many beta-blockers are cleared by the kidneys, and CKD patients are more vulnerable to side effects like dangerously low heart rate or blood pressure drops.
The evidence in favor of using them, at least in CKD patients who also have heart failure, is strong. A systematic review and meta-analysis found that beta-blockers reduced all-cause death by about 28 percent and cardiovascular death by about 34 percent in CKD patients with heart failure, compared to placebo. The tradeoff was a roughly fivefold increase in the risk of both bradycardia and hypotension.12PubMed. Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis Those side effects are manageable with careful dosing but underscore why these drugs need close monitoring in CKD.
Among elderly patients specifically, beta-blocker use was linked to about a 49 percent lower risk of death in those with heart failure and reduced heart pumping function. That benefit persisted across CKD stages, from moderate to severe kidney impairment.13PubMed Central. Beta-blocker therapy in elderly patients with renal dysfunction and heart failure A separate observational study confirmed that beta-blocker therapy was associated with lower risk of death or heart failure hospitalization among CKD patients with impaired heart function.14PubMed Central. Effectiveness of β-Blockers in Heart Failure With Left Ventricular Systolic Dysfunction and Chronic Kidney Disease
A gap in the evidence is worth noting: most of the beta-blocker research in CKD has focused on patients who already have heart failure. Whether slowing the heart rate with medication benefits CKD patients who have a fast pulse but no diagnosed heart failure is less clear, and this remains an active area of investigation.
Exercise and Other Non-Drug Approaches
Regular physical activity is one of the few interventions that addresses multiple CKD-related mechanisms at once. It can improve autonomic balance, reduce sympathetic tone, lower resting blood pressure, and improve the body’s ability to use oxygen more efficiently with each heartbeat. A Cochrane review of exercise in CKD pulled together data from 24 studies and found that structured exercise programs significantly improved aerobic fitness and walking capacity. On the cardiovascular side, exercise lowered resting systolic blood pressure by about 6 mmHg and resting heart rate by about 6 beats per minute.15Cochrane Database of Systematic Reviews. Exercise therapy for adults with chronic kidney disease
That said, a more recent meta-analysis focusing specifically on aerobic training in CKD did not find a statistically significant change in resting heart rate between exercise and control groups.16PubMed. Aerobic exercise in adults with chronic kidney disease (CKD): a meta-analysis The discrepancy likely reflects differences in study design, exercise intensity, and the types of CKD patients enrolled. The broader Cochrane review included a wider range of exercise modalities and study sizes. What both analyses agree on is that exercise in CKD is safe and beneficial for overall fitness and blood pressure, even if its effect on heart rate specifically remains somewhat inconsistent across trials.
Beyond formal exercise programs, managing fluid intake between dialysis sessions can reduce the autonomic roller coaster that drives heart rate spikes during treatment. And treating anemia with erythropoiesis-stimulating agents, when indicated, can reduce the compensatory tachycardia caused by low hemoglobin.
What Happens After a Kidney Transplant
If the diseased kidneys are a major source of the signals driving sympathetic overdrive, removing them should help. And to a degree, it does. Research on kidney transplant recipients shows that successful transplantation improves reflex cardiovascular control and leads to a reduction in sympathetic nerve activity, particularly when the native diseased kidneys are removed along with the transplant.17PubMed Central. Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation This provides further evidence that the kidneys themselves, not just the metabolic consequences of their failure, are actively generating the sympathetic signals that speed up the heart.
Recovery is not always complete, though. Patients who receive a transplant but retain their native kidneys may continue to experience some degree of sympathetic overactivity. And the immunosuppressive drugs used to prevent organ rejection, particularly calcineurin inhibitors like cyclosporine and tacrolimus, can themselves raise blood pressure and affect autonomic function. So while transplantation often improves the picture, it does not erase every CKD-related cardiovascular abnormality overnight.
Pulse Rate in Children with CKD
CKD is not exclusively an adult condition, and the autonomic disturbances it causes appear early in life. A study from the Chronic Kidney Disease in Children (CKiD) cohort used ambulatory blood pressure monitors to measure heart rate variability around the clock in children with CKD. Hypertensive children showed about an 8 percent reduction in heart rate variability compared to children with normal blood pressure, mirroring the autonomic dysfunction seen in adults.18PubMed Central. Heart rate and blood pressure variability in children with chronic kidney disease: A report from the CKiD study These children also showed expected patterns of lower variability during sleep compared to waking hours, but the gap between hypertensive and normotensive children persisted across both states.
This matters because autonomic dysfunction that begins in childhood has decades to cause damage. Early identification through ambulatory monitoring could, in theory, allow clinicians to intervene with blood pressure control and lifestyle changes before the cascade of cardiac remodeling and vascular stiffening takes hold. How aggressively to treat elevated heart rate in pediatric CKD, however, is a question without strong trial evidence to guide it.
Medications That Can Make Things Worse
CKD patients typically take a long list of medications, and several of them can inadvertently push heart rate higher. Vasodilators used for blood pressure control, such as hydralazine and minoxidil, trigger reflex tachycardia as the body tries to compensate for the sudden drop in vascular resistance. Some immunosuppressants, particularly those used after transplantation, affect autonomic tone. Even erythropoiesis-stimulating agents, used to treat the anemia described earlier, can raise blood pressure and secondarily increase heart rate if blood pressure overshoots the target. Phosphate binders, diuretics, and other staples of CKD management each carry their own minor hemodynamic effects that, stacked together, may contribute to a faster resting pulse. If you have CKD and notice a new or worsening elevation in your resting heart rate, a medication review with your nephrologist is a reasonable first step before assuming the disease itself is to blame.